InvestorsHub Logo
Followers 20
Posts 1097
Boards Moderated 0
Alias Born 03/09/2014

Re: BioNewton post# 49339

Monday, 06/06/2016 6:35:09 PM

Monday, June 06, 2016 6:35:09 PM

Post# of 144815
This is how virtually all biotech / consulting firms like McKinsey approach valuation of targeted licenses (some small differences) but this is the gist of it.

Just got sick of the debate.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PMCB News